Initiation or switching β blockers is not recommended in patients experiencing a severe decompensation of HF (e.g., requiring intravenous positive inotropic agents, vasodilators, or mechanical ...
These patient generally need inotropic or vasopressor drugs – which often have harmful side effects that WINT believes istaroxime can potentially avoid – to manage their care. The company’s ...